Cohn & Wolfe set for PR blitz around GSK’s NiQuitin CQ

GlaxoSmithKline Consumer Healthcare has hired Cohn & Wolfe in place of Munro & Forster Communications as retained agency for its smoking-cessation brand NiQuitin CQ.

The switch follows NiQuitin CQ’s sponsorship of the BMW-Williams Formula 1 team, a deal, unveiled two months ago, that is the first tie-in between a smoking-cessation product and a Grand Prix racing team.

C&W – whose contract, won without a pitch, was sealed a fortnight ago – is planning a blitz of PR activity that will focus on next month’s British Grand Prix at Silverstone.

M&F had promoted NiQuitin CQ to consumers and healthcare professionals for five years, but GSK repitched the remit as a result of the PR demands of the F1 link-up.

C&W sponsorship head Karen Osborne, who heads a three-strong account team, said work would include media ‘exploitation’ to promote NiQuitin CQ’s involvement in a sport traditionally associated with pro-tobacco messages. Despite the changed remit, it is understood C&W’s fees remain similar to those picked up by M&F.

The NiQuitin CQ range comprises patches, lozenges and gum.

l 90TEN Marketing and PR this week launched a fresh PR campaign for GSK’s HIV products, including Trizivir. The campaign – for which 90TEN has also devised print advertising and online work – is targeting black Africans and the gay community in the UK, in a bid to ‘get them to take a long-term view of their health,’ according to 90TEN director Paul Tanner.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in